BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35181316)

  • 1. Sensitive UHPLC-MS/MS quantification method for 4β- and 4α-hydroxycholesterol in plasma for accurate CYP3A phenotyping.
    Suzuki Y; Oda A; Negami J; Toyama D; Tanaka R; Ono H; Ando T; Shin T; Mimata H; Itoh H; Ohno K
    J Lipid Res; 2022 Mar; 63(3):100184. PubMed ID: 35181316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of effects of indoxyl sulfate and parathyroid hormone on CYP3A activity considering the influence of CYP3A5 gene polymorphisms.
    Oda A; Suzuki Y; Yoshijima C; Sato H; Tanaka R; Ono H; Tatsuta R; Ando T; Shin T; Itoh H; Ohno K
    Br J Clin Pharmacol; 2023 Dec; 89(12):3648-3658. PubMed ID: 37522799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of P450 3A4 endogenous biomarker - 4β-hydroxycholesterol - in human plasma using LC/ESI-MS/MS.
    Huang MQ; Lin W; Wang W; Zhang W; Lin ZJ; Weng N
    Biomed Chromatogr; 2014 Jun; 28(6):794-801. PubMed ID: 24861746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4β-Hydroxycholesterol as an Endogenous Biomarker for CYP3A Activity: Literature Review and Critical Evaluation.
    Penzak SR; Rojas-Fernandez C
    J Clin Pharmacol; 2019 May; 59(5):611-624. PubMed ID: 30748026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-ESI-MS/MS quantification of 4β-hydroxycholesterol and cholesterol in plasma samples of limited volume.
    Xu Y; Yuan Y; Smith L; Edom R; Weng N; Mamidi R; Silva J; Evans DC; Lim HK
    J Pharm Biomed Anal; 2013 Nov; 85():145-54. PubMed ID: 23948760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations on the Development of a Bioanalytical Assay for 4β-Hydroxycholesterol, an Emerging Endogenous Biomarker of CYP3A Activity.
    Aubry AF; Dean B; Diczfalusy U; Goodenough A; Iffland A; McLeod J; Weng N; Yang Z
    AAPS J; 2016 Sep; 18(5):1056-1066. PubMed ID: 27350147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of 4β-Hydroxycholesterol Plasma Concentrations as an Endogenous Biomarker of CYP3A Activity: Clinical Validation in Individuals With Type 2 Diabetes.
    Gravel S; Chiasson JL; Gaudette F; Turgeon J; Michaud V
    Clin Pharmacol Ther; 2019 Oct; 106(4):831-840. PubMed ID: 31002385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy Increases CYP3A Enzymes Activity as Measured by the 4β-Hydroxycholesterol/Cholesterol Ratio.
    Mlugu EM; Minzi OM; Kamuhabwa AAR; Diczfalusy U; Aklillu E
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4β-Hydroxycholesterol, an endogenous marker of CYP3A4/5 activity in humans.
    Diczfalusy U; Nylén H; Elander P; Bertilsson L
    Br J Clin Pharmacol; 2011 Feb; 71(2):183-9. PubMed ID: 21219398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid LC-MS/MS method for the determination of 4-hydroxycholesterol/cholesterol ratio in serum as endogenous biomarker for CYP3A activity in human and foals.
    Hasan M; Siegmund W; Oswald S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():193-199. PubMed ID: 27565568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of 4β-Hydroxycholesterol and 25-Hydroxycholesterol as Endogenous Biomarkers of CYP3A4: Study with CYP3A-Humanized Mice.
    Nitta SI; Hashimoto M; Kazuki Y; Takehara S; Suzuki H; Oshimura M; Akita H; Chiba K; Kobayashi K
    AAPS J; 2018 Apr; 20(3):61. PubMed ID: 29858698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4β-hydroxycholesterol as an endogenous CYP3A marker in cancer patients treated with taxanes.
    de Graan AJ; Sparreboom A; de Bruijn P; de Jonge E; van der Holt B; Wiemer EA; Verweij J; Mathijssen RH; van Schaik RH
    Br J Clin Pharmacol; 2015 Sep; 80(3):560-8. PubMed ID: 26119961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved synthesis and in vitro evaluation of the cytotoxic profile of oxysterols oxidized at C4 (4α- and 4β-hydroxycholesterol) and C7 (7-ketocholesterol, 7α- and 7β-hydroxycholesterol) on cells of the central nervous system.
    Nury T; Samadi M; Zarrouk A; Riedinger JM; Lizard G
    Eur J Med Chem; 2013; 70():558-67. PubMed ID: 24211631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4β-Hydroxycholesterol as an endogenous biomarker of CYP3A activity in cynomolgus monkeys.
    Li K; Zhao S; Zhang L; Wu X; Shu P; Wang Y; Feng H; Gu Z; Han Hsu H
    Drug Metab Dispos; 2014 May; 42(5):839-43. PubMed ID: 24595680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A validated liquid chromatography-tandem mass spectrometry method for the quantitative determination of 4β-hydroxycholesterol in human plasma.
    van de Merbel NC; Bronsema KJ; van Hout MW; Nilsson R; Sillén H
    J Pharm Biomed Anal; 2011 Jul; 55(5):1089-95. PubMed ID: 21507593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No impact of vitamin D on the CYP3A biomarker 4β-hydroxycholesterol in patients with abnormal glucose regulation.
    Mannheimer B; Wagner H; Östenson CG; Diczfalusy U
    PLoS One; 2015; 10(4):e0121984. PubMed ID: 25835492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of 4-beta-hydroxycholesterol in human plasma using automated sample preparation and LC-ESI-MS/MS analysis.
    Goodenough AK; Onorato JM; Ouyang Z; Chang S; Rodrigues AD; Kasichayanula S; Huang SP; Turley W; Burrell R; Bifano M; Jemal M; LaCreta F; Tymiak A; Wang-Iverson D
    Chem Res Toxicol; 2011 Sep; 24(9):1575-85. PubMed ID: 21728364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4.
    Bodin K; Bretillon L; Aden Y; Bertilsson L; Broomé U; Einarsson C; Diczfalusy U
    J Biol Chem; 2001 Oct; 276(42):38685-9. PubMed ID: 11514559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative performance of oral midazolam clearance and plasma 4β-hydroxycholesterol to explain interindividual variability in tacrolimus clearance.
    Vanhove T; de Jonge H; de Loor H; Annaert P; Diczfalusy U; Kuypers DR
    Br J Clin Pharmacol; 2016 Dec; 82(6):1539-1549. PubMed ID: 27501475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of induced CYP3A activity in pregnant women using 4β-hydroxycholesterol: Cholesterol ratio as an appropriate metabolic marker.
    Kim AH; Kim B; Rhee SJ; Lee Y; Park JS; Lee SM; Kim SM; Lee S; Yu KS; Jang IJ; Cho JY
    Drug Metab Pharmacokinet; 2018 Jun; 33(3):173-178. PubMed ID: 29759884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.